Our corporation is a joint venture company of Shandong Lukang Pharmaceutical Corporation and Shanghai Record Pharmaceuticals Co., Ltd., established in early 2007. We developed from Shandong Lukang Pharmaceutical Corporation, which has a long history of 40 years. Since that time, we have grown to become a leading supplier of pharmaceutical raw materials and special resins for ion exchange, absorbents and special applications for worldwide markets.
2018-05-22
Amicogen announces US FDA Approval for the product of Ceftiofur sodium sterile, Ceftiofur Hcl sterile & non-sterile, Tulathromycin. This was the first FDA inspection of Amicogen. While Amicogen’s products have been sold for a number of years in Europe (also under the former Shandong Lukang Record name), this now opens up our products to users in the USA.
2018-05-22
We will participate in the The on 20 - 23 June. in Shanghai for CPhI China 2018. Our booth: E2B08 Welcome to visit our booth!
2016-09-21
We will participate in the The on 03 - 05 Oct. in Barcelona for CPhI Worldwide 2016. Our booth: 6H56 Welcome to visit our booth!
2016-08-13
We will participate in the The on 26 - 28 June in Shanghai for CPhI China 2014 Our booth: E1P18 Welcome to visit our booth!